Work

KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Cystic Fibrosis

DOI: 10.1016/j.jcf.2017.12.006

Authors: Raksha Jain, V.V. Beckett, M.W. Konstan, F.J. Accurso, J.L. Burns, N. Mayer-Hamblett, Carlos Milla, D.R. VanDevanter, J.F. Chmiel

Institutions: The University of Texas Southwestern Medical Center, Seattle Children's Research Institute, Rainbow Babies & Children's Hospital, Case Western Reserve University, Seattle Children's Hospital, University of Washington, Stanford University

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2777692148

FWCI: 6.487

Cites: 31

Cited by: 108

Related to: 10